Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms

Neurobiology of Learning and Memory

Volumn 91, Issue 4, 2009, Pages 393-401

  Goeldner, Celia ^a,b   Reiss, Davids ^b   Wichmann, Jürgen ^c   Kieffer, Brigitte L ^b   Ouagazzal, Abdel Mouttalib ^d  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d CNRS   (France)

Author keywords

Glutamate; Learning; Memory; Mice; NOP receptor

Indexed keywords

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING (PSYCHOLOGY); CUES; DIZOCILPINE MALEATE; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; FEAR; GLUTAMIC ACID; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MORPHINE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; SPIRO COMPOUNDS;

EID: 62749092030     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2008.12.001     Document Type: Article

References (63)

1. Ahi J., Radulovic J., and Spiess J. The role of hippocampal signaling cascades in consolidation of fear memory. Behavioural Brain Research 149 (2004) 17-31
2. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., and Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. Neuroreport 9 (1998) 2265-2267
3. Bardgett M.E., Boeckman R., Krochmal D., Fernando H., Ahrens R., and Csernansky J.G. NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice. Brain Research Bulletin 60 (2003) 131-142
4. Bast T., Zhang W.N., and Feldon J. Dorsal hippocampus and classical fear conditioning to tone and context in rats: Effects of local NMDA-receptor blockade and stimulation. Hippocampus 13 (2003) 657-675
5. Bolivar V.J., Pooler O., and Flaherty L. Inbred strain variation in contextual and cued fear conditioning behavior. Mammalian Genome 12 (2001) 651-656
6. Bongsebandhu-phubhakdi S., and Manabe T. The neuropeptide nociceptin is a synaptically released endogenous inhibitor of hippocampal long-term potentiation. Journal of Neuroscience 27 (2007) 4850-4858
7. Calo' G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: A novel therapeutic target. British Journal of Pharmacolgy 129 (2000) 1261-1283
8. Cavallini S., Marino S., Beani L., Bianchi C., and Siniscalchi A. Nociceptin inhibition of acetylcholine efflux from different brain areas. Neuroreport 14 (2003) 2167-2170
9. Chang S.D., Chen D.Y., and Liang K.C. Infusion of lidocaine into the dorsal hippocampus before or after the shock training phase impaired conditioned freezing in a two-phase training task of contextual fear conditioning. Neurobiology of Learning and Memory 89 (2008) 95-105
10. Chiou L.C., Liao Y.Y., Fan P.C., Kuo P.H., Wang C.H., Riemer C., et al. Nociceptin/orphanin FQ peptide receptors: Pharmacology and clinical implications. Current Drug Targets 8 (2007) 117-135
11. Darland T., and Grandy D.K. The orphanin FQ system: An emerging target for the management of pain?. British Journal of Anaesthesia 81 (1998) 29-37
12. Fanselow M.S. Contextual fear, gestalt memories, and the hippocampus. Behavioural Brain Research 110 (2000) 73-81
13. Fanselow M.S., and Poulos A.M. The neuroscience of mammalian associative learning. Annual Review of Psychology 56 (2005) 207-234
14. Figueredo L.Z., Moreira K.D., Ferreira T.L., Fornari R.V., and de Oliveira M.G. Interaction between glutamatergic-NMDA and cholinergic-muscarinic systems in classical fear conditioning. Brain Research Bulletin 77 (2008) 71-76
15. Fornari R.V., Soares J.C., Ferreira T.L., Moreira K.M., and Oliveira M.G. Effects of nociceptin/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats. Behavioural Neuroscience 122 (2008) 98-106
16. Frankland P.W., Josselyn S.A., Anagnostaras S.G., Kogan J.H., Takahashi E., and Silva A.J. Consolidation of CS and US representations in associative fear conditioning. Hippocampus 14 (2004) 557-569
17. Giovannini M.G. The role of the extracellular signal-regulated kinase pathway in memory encoding. Reviews in the Neurosciences 17 (2006) 619-634
18. Glover E.M., and Davis M. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: Tolerance, cross-tolerance, and blockade by naloxone. Psychopharmacology 198 (2008) 167-180
19. Goeldner C., Reiss D., Wichmann J., Meziane H., Kieffer B.L., and Ouagazzal A.M. Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. Journal of Neuroscience 28 (2008) 2190-2198
20. Gold P.E. Acetylcholine modulation of neural systems involved in learning and memory. Neurobiology of Learning and Memory 80 (2003) 194-210
21. Gould T.J., McCarthy M.M., and Keith R.A. MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cue fear conditioning. Behavioural Pharmacology 13 (2002) 287-294
22. Higgins G.A., Kew J.N., Richards J.G., Takeshima H., Jenck F., Adam G., et al. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. European Journal Neuroscience 15 (2002) 911-922
23. Hirao A., Imai A., Sugie Y., Yamada Y., Hayashi S., and Toide K. Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent. Pharmacological Science 106 (2008) 361-368
24. Homayoun H., Khavandgar S., and Zarrindast M.R. Morphine state-dependent learning: Interactions with alpha2-adrenoceptors and acute stress. Behavioural Pharmacology 14 (2003) 41-48
25. Jenck F., Moreau J.-L., Martin J.R., Kilpatrick G., Reinscheid R., Monsma F.J., et al. Orphanin FQ acts as anxiolytic to attenuate behavioral responses to stress. Proceedings of the National Academy of Sciences USA 94 (1997) 4854-14858
26. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R., et al. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat. Proceedings of the National Academy of Sciences USA 97 (2000) 4938-4943
27. Kahveci N., Gulec G., and Ozluk K. Effects of intracerebroventricularly-injected morphine on anxiety, memory retrieval and locomotor activity in rats: Involvement of vasopressinergic system and nitric oxide pathway. Pharmacology Biochemistry and Behavior 85 (2006) 859-867
28. Kawahara Y., Hesselink M.B., van Scharrenburg G., and Westerink B.H. Tonic inhibition by orphanin FQ/nociceptin of noradrenaline neurotransmission in the amygdala. European Journal of Pharmacolgy 485 (2004) 197-200
29. Koks S., Soosaar A., Voikar V., Bourin M., and EVasar E. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze. Neuropeptides 33 (1999) 63-69
30. Lambert D.G. The nociceptin/orphanin FQ receptor: A target with broad therapeutic potential. Nature Reviews. Drug Discovery 7 (2008) 694-710
31. LeDoux J.E. Emotion circuits in the brain. Annual Review of Neuroscience 23 (2000) 155-184
32. Mamiya T., Yamada K., Miyamoto Y., Konig N., Watanabe Y., Noda Y., et al. Neuronal mechanism of nociceptin-induced modulation of learning and memory: Involvement of N-methyl-d-aspartate receptors. Molecular Psychiatry 8 (2003) 752-765
33. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394 (1998) 577-581
34. Matus-Amat P., Higgins E.A., Sprunger D., Wright-Hardesty K., and Rudy J.W. The role of dorsal hippocampus and basolateral amygdala NMDA receptors in the acquisition and retrieval of context and contextual fear memories. Behavioral Neuroscience 121 (2007) 721-731
35. Meis S. Nociceptin/orphanin FQ: Actions within the brain. Neuroscientist 9 (2003) 158-168
36. Micheau J., and Riedel G. Protein kinases: Which one is the memory molecule?. Cellular and Molecular Life Science 55 (1999) 534-548
37. Nabeshima T., Noda Y., and Mamiya T. The role of nociceptin in cognition. Brain Research 848 (1999) 167-173
38. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. Journal of Comparative Neurology 412 (1999) 563-605
39. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. Journal of Comparative Neurology 406 (1999) 503-547
40. Parada-Turska J., and Turski W.A. Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 29 (1990) 1111-1116
41. Parron C., Poucet B., and Save E. Cooperation between the hippocampus and the entorhinal cortex in spatial memory: A disconnection study. Behavioural Brain Research 170 (2006) 99-109
42. Patti C.L., Kameda S.R., Carvalho R.C., Takatsu-Coleman A.L., Lopez G.B., Niigaki S.T., et al. Effects of morphine on the plus-maze discriminative avoidance task: Role of state-dependent learning. Psychopharmacology 184 (2006) 1-12
43. Redrobe J.P., Calo' G., Guerrini R., Regoli D., and Quirion R. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. British Journal of Pharmacology 131 (2000) 1379-1384
44. Reiss D., Wichmann J., Tekeshima H., Kieffer B.L., and Ouagazzal A.M. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice. comparison to morphine. European Journal of Pharmacology 579 (2008) 141-148
45. Roozendaal B., Lengvilas R., McGaugh J.L., Civelli O., and Reinscheid R.K. Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation. Learning and Memory 14 (2007) 29-35
46. Rudy J.W., Huff N.C., and Matus-Amat P. Understanding contextual fear conditioning: Insights from a two-process model. Neuroscience and Biobehavioral Reviews 28 (2004) 675-685
47. Rudy J.W., and O'Reilly R.C. Conjunctive representations, the hippocampus, and contextual fear conditioning. Cognitive Affective & Behavioral Neuroscience 1 (2001) 66-82
48. Sanders M.J., and Fanselow M.S. Pre-training prevents context fear conditioning deficits produced by hippocampal NMDA receptor blockade. Neurobiology of Learning and Memory 80 (2003) 123-129
49. Sandin J., Georgieva J., Schott P.A., Ogren S.O., and Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. European Journal of Neuroscience 9 (1997) 194-197
50. Sandin J., Ogren S.O., and Terenius L. Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Research 997 (2004) 222-233
51. Schlicker E., and Morari M. Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides 21 (2000) 1023-1029
52. Stiedl O., Birkenfeld K., Palve M., and Spiess J. Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV. Behavioural Brain Research 116 (2000) 157-168
53. Stote D.L., and Fanselow M.S. NMDA receptor modulation of incidental learning in Pavlovian context conditioning. Behavioral Neuroscience 118 (2004) 253-257
54. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Current Opinion in Neurobiology 14 (2004) 311-317
55. Tallent MK. Presynaptic inhibition of glutamate release by neuropeptides: Use-dependent synaptic modification. Results and Problems in Cell Differentiation 44 (2008) 177-200
56. Tinsley M.R., Quinn J.J., and Fanselow M.S. The role of muscarinic and nicotinic cholinergic neurotransmission in aversive conditioning: Comparing pavlovian fear conditioning and inhibitory avoidance. Learning & Memory 11 (2004) 35-42
57. Uezu K., Sano A., Sei H., Toida K., Houtani T., Sugimoto T., et al. Enhanced hippocampal acetylcholine release in nociceptin-receptor knockout mice. Brain Research 1050 (2005) 118-123
58. Varty G.B., Lu S.X., Morgan C.A., Cohen-Williams M.E., Hodgson R.A., Smith-Torhan A., et al. The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510). Journal of Pharmacology and Experimental Therapeutics 326 (2008) 672-682
59. Wei W.Z., and Xie C.W. Orphanin FQ suppresses NMDA receptor-dependent long-term depression and depotentiation in hippocampal dentate gyrus. Learning & Memory 6 (1999) 467-477
60. Wichmann J., Adam G., Rover S., Hennig M., Scalone M., Cesura A.M., et al. Synthesis of (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties. European Journal Medicinal Chemistry 35 (2000) 839-851
61. Winslow J.T., Noble P.L., and Davis M. Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone. Biological Psychiatry 61 (2007) 389-395
62. Yu T.P., Fein J., Phan T., Evans C.J., and Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 7 (1997) 88-94
63. Zarrindast M.R., Bananej M., Khalilzadeh A., Fazli-Tabaei S., Haeri-Rohani A., and Rezayof A. Influence of intracerebroventricular administration of dopaminergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Neurobiology of Learning and Memory 86 (2006) 286-292